Skip to main content

Bevacizumab Biosimilar Market Analysis by Application and Competitive Insights to 2021

Global Bevacizumab Biosimilar Market by Application spans Analytical, Pharmacokinetic, Clinical Data, Pharmacology, and Toxicology Data. Currently, there is no acknowledged biosimilar for bevacizumab, a monoclonal antibody used for treating advanced solid tumors, counting metastatic colorectal cancer (mCRC) and advanced or metastatic non-squamous non-small-cell lung cancer (mNSCLC).

Bevacizumab is a humanized monoclonal antibody. It constrains angiogenesis (the formation of new blood vessels) by blocking the action of vascular endothelial growth factor A (VEGF-A). Bevacizumab can accordingly slow the growth of new blood vessels in tumor’s and is used to treat various cancers, including colorectal, lung, breast, glioblastoma, kidney and ovarian.


In the United States, it is accepted for giving glioblastoma (GBM) and metastatic ovarian cancer (mOC), and in the European Union (EU) it is indicated for patients with metastatic breast cancer (mBC). Bevacizumab has been exposed to prolong existence in patients with these cancers when combined with chemotherapy in the global Bevacizumab Biosimilar Industry. The measured physicians who did not regularly endorse bevacizumab, those from emerging markets were more probable to cite access as a fence to indorsing across all tumors types. Further, physicians in the United States and EU found it easier to access the drug when treating patients with mCRC, mNSCLC, and mOC than physicians in emerging markets.

U.S. physicians could willingly admit bevacizumab for treatment of GBM than physicians in the other two markets, while EU physicians found it easier to admission the drug for mBC. The major reasons for the apparent barriers to access were that the drug’s costs were “not compensated by healthcare system/private insurance,” and the high out-of-pocket (OOP) costs to the patient. These fences were most commonly cited by physicians in developing markets, although more than high of American defendants said lack of repayment was a barrier to recommending the drug for mOC, associated with 55% of physicians in developing markets and just in the EU.

Of the physicians who had to reduce the number of cycles agreed, the most common reason across all markets and tumor types was the lack of reimbursement. Global Bevacizumab Biosimilar Market by Geographical Region spans North America, Europe, China, Japan, Southeast Asia, and India. Global Bevacizumab Biosimilar Industry Key Players include Pfizer, Allergan, Alnylam Pharmaceuticals, Amgen, Angstrom Pharmaceuticals, Acceleron Pharma, Biocon, Bionomics, and CASI Pharmaceuticals.


Comments

Popular posts from this blog

RFID Smart Cabinet Market Share, Distributor Analysis, Development Trends 2021

Global RFID smart cabinet market is segmented into standard form and customized form, based on product. RFID smart cabinet serves multiple objectives for various business domains. One of the most profound uses of RFID smart cabinets caters to hospitals and medical institutions. Using a patent protected RFID technique coupled with point-of-use reporting, smart cabinets enable a precise, real-time inventory management at the stock and inventory level. Technically, RFID smart cabinet works on RFID principle. RFID labels are placed on item package or box and the item’s barcode gets scanned to enroll into the system. Enrolled stock is then ready for placement in the smart cabinet. Individual stock is then placed on the shelves with the RFID tags facing towards the rear of cabinet. In the end, cabinet doors are closed & items are ready for use. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/rfid-smart-cabinet-market On a commercial scale, R...

Chlortetracycline (Feed Grade) Market Latest Trends & Forecasts Report By 2025

25 th January 2019 -   Global Chlortetracycline (Feed Grade) Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Chlortetracycline (CTC) Feed Grade is also termed as chlortetracycline is an antimicrobial drug effective against gram-negative and gram-positive bacterium and other pathogenic bacteria like rickettsia, chlamydia, and mycoplasma. It is exclusively used in the treatment of cholera, white dysentery, paratyphoid, enteritis, typhoid, and pneumonia in livestock and poultry. It is available as a brown to dark brown powder. It also used in animals that are usually administered in the feed for prophylactic purposes and also increases the reward of feed. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/chlortetracycline-feed-grade-market Chlortetracycline (Feed Grade) Market is segmented based on product types, applications, and region. Product t...

Sugar Sphere Market Share, Size & Competitive Insights to 2022

Global sugar sphere market is segmented on the basis of type, application and geography. Sugar spheres are also known as neutral pellets, microgranules or sugar beads, nonpareil seeds. It is produced, often by using a layered sugar-coating structure. Sugar spheres are a commonly used excipient with respect to sustained-release pellet formulations utilized in oral dosage forms. The preferably rounded sugar spheres exist closely graduated particle sizes. They are then covered with sustained release additives and the active substance. Pellets could be made into tablets or used for filling capsules, with suitable additives. To ensure uniform coating, circular shape is best-suited and pellets are good with respect to automatic dosing. Sugar spheres and cellulose spheres (celphere) are pharmaceutical samples of comparable size distributions. They are also measured using sphere recognition and image processing. The reconstructions for sugar spheres and cellulose spheres (celphere) are s...